Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and

Details Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and

1979-12-31

1982-01-19

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

Conjugated via claimed linking group, bond, chelating agent,...

424310, 424319, 424343, 424361, A61K 3170, A61K 31715

Patent

active

043116949

ABSTRACT:
A composition of matter in pharmaceutical dosage form comprising an amorphous coprecipitate of water-soluble polyhydroxylic organic compounds and 4-(monoalkylamino)-benzoic acid and derivatives for the treatment of atherosclerosis and hyperlipidemia.

REFERENCES:
patent: 3200039 (1965-08-01), Thompson
patent: 3691281 (1972-09-01), Battista
patent: 3751277 (1973-08-01), Small et al.
patent: 3868416 (1975-02-01), Albright et al.
patent: 3962420 (1976-06-01), Seidel et al.
patent: 4059686 (1977-11-01), Tanaka et al.
Chion et al., J. Pharmaceutical Sciences, vol. 58, pp. 1505-1509, 1969.

Affiliated with

Also associated with

Rating

Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amorphous coprecipitates of 4-(monoalkylamino) benzoic acid and will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1915070